Patents by Inventor Peter Kleindl

Peter Kleindl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platinum(IV) conjugates and methods of use
    Patent number: 11458163
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: October 4, 2022
    Assignees: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF
    Publication number: 20220177472
    Abstract: The present technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using the same for the treatment of cancers and as vaccine adjuvants.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 9, 2022
    Applicants: UNIVERSITY OF KANSAS, HYLAPHARM, LLC.
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • PLATINUM(IV) CONJUGATES AND METHODS OF USE
    Publication number: 20200330507
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Applicants: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai